Process for Production of Triterpene Alcohol
    3.
    发明申请
    Process for Production of Triterpene Alcohol 有权
    三萜醇生产工艺

    公开(公告)号:US20130137883A1

    公开(公告)日:2013-05-30

    申请号:US13816778

    申请日:2011-08-19

    Abstract: A process for producing triterpene alcohol, comprising sequentially conducting the following steps (A) to (C): (A) subjecting γ-oryzanol to alkaline hydrolysis; (B) mixing the alkaline hydrolysate with a low polarity organic solvent, and extracting triterpene alcohol to obtain a triterpene alcohol-containing low polarity organic solvent; and (C) adding water to the triterpene alcohol-containing low polarity organic solvent thus obtained, removing the low polarity organic solvent, and then melting triterpene alcohol in hot water, followed by cooling.

    Abstract translation: 一种制备三萜醇的方法,包括依次进行下列步骤(A)至(C):(A)使γ-谷维素进行碱水解; (B)将碱性水解产物与低极性有机溶剂混合,萃取三萜醇得到含三萜醇的低极性有机溶剂; 和(C)向由此得到的三萜烯醇低极性有机溶剂中加入水,除去低极性有机溶剂,然后在热水中熔融三萜烯醇,然后冷却。

    Agent for improving insulin resistance
    6.
    发明授权
    Agent for improving insulin resistance 有权
    改善胰岛素抵抗的药物

    公开(公告)号:US07947669B2

    公开(公告)日:2011-05-24

    申请号:US12064607

    申请日:2006-09-22

    Abstract: To inhibit production of adipocytokines, in particular, adipocytokines that elicit insulin resistance and to prevent onset of pathosis caused by the insulin resistance, or improve the pathosis, the present invention provides an agent or a food or drink which contains a compound having a cyclolanostane skeleton, or an organic solvent extract, a hot water extract of a plant of the family Liliaceae or Gramineae, or a fraction thereof which contains the compound as an active ingredient.

    Abstract translation: 为了抑制脂肪细胞因子的产生,特别是引起胰岛素抵抗和预防由胰岛素抵抗引起的病变发作或改善病变的脂肪细胞因子,本发明提供了含有具有环氨基苯甲酸骨架的化合物的药剂或食品或饮料 或有机溶剂提取物,百合科或禾本科植物的热水提取物,或其部分含有该化合物作为活性成分。

    Neuroactive 13, 24-cyclo-18, 21-dinorcholanes and structurally related pentacyclic steriods
    8.
    发明授权
    Neuroactive 13, 24-cyclo-18, 21-dinorcholanes and structurally related pentacyclic steriods 有权
    神经活性13,24-环-18,21-二硼胆碱和结构相关的五环类固醇

    公开(公告)号:US07781421B2

    公开(公告)日:2010-08-24

    申请号:US10856314

    申请日:2004-05-28

    CPC classification number: C07J53/002 C07J53/00 C07J71/001

    Abstract: Novel pentacyclic steroids and pentacyclic D-homosteroids comprising: (i) the tetracyclic steroid ring system or tetracyclic D-homosteroid ring system, respectively; (ii) a C(3) substituent selected from the group consisting of (a) a hydroxyl or carboxyl in the α-configuration and (b) a sulfate or other negatively charged moiety; and (iii) a fused fifth ring, the fused fifth ring comprising a hydrogen bond acceptor, and (a) in the case of the pentacyclic steroid the C(13) and C(17) carbons, or (b) in the case of the pentacyclic D-homosteroid the C(13) and C(17a) carbons, having utility as anesthetics and in the treatment of disorders relating to GABA function and activity.

    Abstract translation: 新型五环类固醇和五环D-类固醇激素分别包括:(i)四环类固醇环系统或四环D-类固醇环系统; (ii)选自(a)α-构型的羟基或羧基和(b)硫酸盐或其它带负电荷的部分的C(3)取代基; 和(iii)稠合的第五环,所述稠合的第五环包含氢键受体,和(a)在五环类固醇的情况下,C(13)和C(17)的碳,或(b)在 五环D-类固醇,C(13)和C(17a)碳,可作为麻醉剂用于治疗与GABA功能和活性有关的疾病。

Patent Agency Ranking